In this episode, Ellie Handy is joined by Dr Chen Mao Davies, Founder and CEO of Anya, to explore what it really takes to bring a digital women’s health product to market.

Chen shares the story behind Anya’s creation, the gaps she identified in maternal healthcare, and how AI-powered support can deliver accessible, 24/7 care for women and new parents. The conversation dives into the practical realities of scaling a femtech product, navigating NHS procurement and meeting rigorous digital health standards.

They also discuss the contrasting route to market through private employers, highlighting the growing demand for workplace wellbeing solutions and the different commercial drivers at play.

A must-listen for founders, investors and anyone interested in the future of women’s health innovation.

Learn more about Anya.

Discover Bristows expertise in the women's health space.

IP & AI litigation: Getty Images v Stability AI explained

Stop and get into the ever-evolving brandscape of intellectual property and advertising. In each Bristows – Cease and Discuss episode, our Brands, Designs and Copyright team will sit down and discuss an aspect of IP law and advertising, with some practical takeaways and catch ups on developments and changes.

In this first episode, Jeremy Blum and Toby Headdon discuss the outcome and potential consequences of the first case in the UK which addresses copyright, trade marks and AI - Getty Images v Stability AI.

Note: All information was correct at the time of recording.

In this episode of our Spotlight on Women's Health and Innovation podcast, Maria Ryan and Melissa Dix explore how patenting trends offer a window into research activities in the women’s health space. They discuss the rise in patenting of female-specific inventions, and consider female representation in patent inventorship.

You can read our full article on the same topic here.

In today's podcast, Richard Pinckney and Naoise Gaffney disseminate the key takeaways from the Supreme Court's decision in Emotional Perception AI v Comptroller General, which has brought about a seismic shift in the way that patentability of Computer Implemented Inventions is to be assessed in the UK.

This is a follow-up to Naoise's stop press article last week on the same topic. Click here to read it now.

Those working in the Femtech space have a difficult regulatory framework to navigate in the EU. For products that qualify as a medical device, the EU Medical Device Regulation imposes onerous obligations. In addition, the AI Act, as it stands, add additional regulatory requirements for devices including AI.

In this podcast Xisca Borrás and Ellie Handy discuss when software will qualify as a medical device, the regulatory obligations for devices and the challenges Femtech manufacturers may face in complying with them. They then cover the interaction between the EU MDR and AI Act, discussing how to navigate them.

In view of the European Commission’s proposal to simplify the rules applicable to medical devices, issued after the recording of this podcast, the impact of the AI Act on medical devices may change significantly in the future, so stay tuned for more updates about the changing landscape that applies to AI.

The FemTech sector, which focuses on technology for women’s health and wellness, is experiencing rapid growth in the UK. Out of the 540 active FemTech start-ups in Europe in 2023, 31.8% were based in the UK, and the UK is ranked second globally (behind the US) in terms of investment in the FemTech sector.

In this podcast, Sophie Rees, Anna Honey and Gabriela Necula outline the main early-stage funding options available to UK-based FemTech companies and highlights key legal considerations at each stage.

Finding reasons to be cheerful…hear our tax team’s key takeaways from the Budget 2025 which was announced on Wednesday, 26 November 2025.

After much speculation and the odd leak, we unpick the negative predictions that did not come to pass and share our top three tax ‘good news’ stories.

All information was correct at the time of recording.

In this episode of our Spotlight on Women's Health and Innovation podcast, Laura Harwood and Melissa Dix explore how university spin-outs can offer an effective mechanism for commercialising research, particularly in the women’s health space. They discuss the way in which university spin-outs are bringing research-driven solutions to market, and examine the key contractual considerations regarding the associated IP.